Brought to you by 
Abbott gets an option to acquire Advanced Cardiac Therapeutics
21 Sep 2020
Executive Summary
Paired with announcements regarding the acquisition of Topera Medical Inc. and a minority investment in VytronUS, Abbott Laboratories Inc. continues on its quest to make a strong entry into the electrophysiology market through also gaining the option to acquire Advanced Cardiac Therapeutics Inc. (ACT), a privately owned firm developing a new cardiac ablation catheter.
Deal Industry
- Medical Devices
Deal Status
- Preliminary
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott gets an option to acquire Advanced Cardiac Therapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice